Nouvelle déclaration d'incident
No de la demande: 2010-3868
Numéro de référence du titulaire d'homologation: PROSAR Case # 1-23138366
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: UNITED STATES
État: NEW YORK
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-63
Nom du produit: Advanced Care 2 in 1 Flea Tick Collar for Cats
Autre (préciser)
collarOui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Professionnel de la santé
Cat / Chat
Domestic shorthair
1
Homme
7
10
lbs
Cutanée
Unknown / Inconnu
Unknown / Inconnu
Système
Persisted until death
Oui
Oui
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
1-23138366- The reporter, a veterinary technician, indicates exposure of a patient to a pesticide containing the active ingredient Tetrachlorvinphos. The caller reports a 7 year 10 pound male domestic shorthair cat had the product, a collar, applied 3 days prior to the initial contact with the registrant. After application of the product the animal was not seen again for 24-48 hours by the owner, as the animal is an outdoor cat and did not return home. When the animal did return home the animal was reported to have developed signs of ataxia, anorexia, seizures and respiratory distress. The animal was brought to the veterinary hospital and given a bath, atropine and intravenous fluids. The reporter also indicated at this point that the animal had developed nasal discharge. The caller was told the signs seen were unexpected following the exposure described. She was advised of signs consistent with organophosphate toxicity, and standard treatment protocols. She was provided information regarding registrant supported cholinesterase blood testing to assist in determining etiology. On routine call back the registrant was advised the animal was no longer seizuring and was "doing better". On yet another call back 6 days after the initial contact with the registrant the DVM attending to the animal advised that the animal had died. She stated the animal continued to improve with palliative care but the animal's owner elected to take the animal home and it began seizuring and died at home. The veterinarian was advised this would be unexpected following routine use of the product as labeled. No further information is available.
Mort